AltraVue Capital LLC 13D and 13G filings for Avid Bioservices, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-01-14 1:49 pm Purchase | 2024-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital LLC | 3,797,813 5.900% | 438,481 (+13.05%) | Filing |
2024-04-17 7:05 pm Purchase | 2024-04-15 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital LLC | 3,359,332 5.300% | 384,999 (+12.94%) | Filing |
2024-01-26 4:57 pm Sale | 2023-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital LLC | 2,974,333 4.700% | -328,627 (-9.95%) | Filing |
2023-01-18 8:03 pm Purchase | 2022-12-31 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital LLC | 3,302,960 5.300% | 192,660 (+6.19%) | Filing |
2022-11-29 4:14 pm Purchase | 2022-11-29 | 13G | Avid Bioservices, Inc. CDMO | AltraVue Capital LLC | 3,110,300 5.003% | 3,110,300 (New Position) | Filing |